[
  {
    "ts": null,
    "headline": "Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025",
    "summary": "FOSTER CITY, Calif., October 13, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will demonstrate progress in our commitment to transform how cancer is treated with new data at the European Society for Medical Oncology (ESMO) 2025 Congress October 17 – 21.",
    "url": "https://finnhub.io/api/news?id=be58eb61e0553a1b92e00a1bfae2bd029166399c328823236b50367c7077afc3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760358600,
      "headline": "Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025",
      "id": 137066431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif., October 13, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will demonstrate progress in our commitment to transform how cancer is treated with new data at the European Society for Medical Oncology (ESMO) 2025 Congress October 17 – 21.",
      "url": "https://finnhub.io/api/news?id=be58eb61e0553a1b92e00a1bfae2bd029166399c328823236b50367c7077afc3"
    }
  }
]